We are live on ! Find out more
IRWD icon

Ironwood Pharmaceuticals
IRWD

140 hedge funds and large institutions have $1.71B invested in Ironwood Pharmaceuticals in 2014 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 45 increasing their positions, 35 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 35

12% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 17

1% more funds holding

Funds holding: 138 → 140 (+2)

12% less capital invested

Capital invested by funds: $1.93B → $1.71B (-$226M)

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

58% less call options, than puts

Call options by funds: $3.06M | Put options by funds: $7.37M

Holders
140
Holders Change
+2
Holders Change %
+1.45%
% of All Funds
4.06%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.06%
New
19
Increased
45
Reduced
35
Closed
17
Calls
$3.06M
Puts
$7.37M
Net Calls
-$4.31M
Net Calls Change
-$6.89M

Top Buyers

Rank Fund Capital Flow
1
JHIU
Janus Henderson Investors US
Colorado
+$92.6M
2
O
OrbiMed
New York
+$42M
3
Deutsche Bank
Deutsche Bank
Germany
+$19.9M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$17.7M
5
Asset Management One
Asset Management One
Japan
+$12.2M

Top Sellers

Rank Fund Capital Flow
1
BI
BVF Inc
California
-$49.4M
2
Millennium Management
Millennium Management
New York
-$27.8M
3
OIM
Oracle Investment Management
Connecticut
-$24.8M
4
TI
Turner Investments
Pennsylvania
-$11.8M
5
TCM
Tamarack Capital Management
California
-$11.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
VOYA Investment Management
76
VOYA Investment Management
Georgia
$847K – – –
TC
77
TFS Capital
Pennsylvania
$831K +$241K +21,030 +38%
MIG
78
Mariner Investment Group
New York
$806K – – –
Macquarie Group
79
Macquarie Group
Australia
$804K – – –
AQR Capital Management
80
AQR Capital Management
Connecticut
$802K +$846K +73,909 New
USAA
81
United Services Automobile Association
Texas
$766K +$65.6K +5,731 +9%
SCI
82
S&CO Inc
Massachusetts
$760K +$214K +18,686 +36%
TAM
83
Tocqueville Asset Management
New York
$654K – – –
PPA
84
Parametric Portfolio Associates
Washington
$640K -$31.1K -2,715 -4%
PP
85
PDT Partners
New York
$599K +$632K +55,220 New
Public Employees Retirement Association of Colorado
86
Public Employees Retirement Association of Colorado
Colorado
$595K – – –
MAA
87
Managed Account Advisors
New Jersey
$577K +$289K +25,245 +90%
UBS AM
88
UBS AM
Illinois
$566K +$12.3K +1,074 +2%
BCM
89
Bourgeon Capital Management
Connecticut
$554K +$64.2K +5,612 +12%
TG
90
TCW Group
California
$532K -$2.74K -239 -0.5%
NSEDCP
91
NJ State Employees Deferred Compensation Plan
New Jersey
$518K – – –
DM
92
Deerfield Management
New York
$475K +$501K +43,764 New
JP Morgan Chase
93
JP Morgan Chase
New York
$463K +$489K +42,715 New
DC
94
Deere & Company
Illinois
$417K +$440K +38,416 New
WC
95
Woodstock Corp
Massachusetts
$368K -$269K -23,454 -41%
Citigroup
96
Citigroup
New York
$351K +$7.26K +634 +2%
MSA
97
Mason Street Advisors
Wisconsin
$336K – – –
BP
98
Banyan Partners
Florida
$328K – – –
CCM
99
Cupps Capital Management
Illinois
$324K +$342K +29,868 New
Principal Financial Group
100
Principal Financial Group
Iowa
$322K – – –
2 3
4
5 6

IRWD Hedge Fund Activity: Q3 2014 in Review

140 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Ironwood Pharmaceuticals (IRWD) for Q3 2014, worth a combined $1.71B — down 12% from $1.93B a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new IRWD positions and 17 closed out — a net gain of 2 holders — while 45 added to existing stakes and 35 trimmed.

The largest buyer was Janus Henderson Investors US, adding an estimated $92.6M. The largest seller was BVF Inc, cutting an estimated $49.4M.

  • 140 institutional investors held Ironwood Pharmaceuticals (IRWD) as of Q3 2014, up from 138 in Q2 2014.
  • Funds reported $1.71B of Ironwood Pharmaceuticals stock for Q3 2014, down 12% quarter-over-quarter.
  • 19 funds opened new Ironwood Pharmaceuticals positions in Q3 2014 and 17 closed out, a net change of +2 holders.
  • The largest Ironwood Pharmaceuticals buyer in Q3 2014 was Janus Henderson Investors US, an estimated $92.6M added.
  • The largest Ironwood Pharmaceuticals seller in Q3 2014 was BVF Inc, an estimated $49.4M sold.

Based on aggregated 13F filings for Q3 2014.